name: Respiratory allergen panel, US - Southern Florida


name: Respiratory allergen panel, US - Southeast coast:-:Pt:Ser:-


name: Respiratory allergen panel, US - Southeast coast


name: Respiratory allergen panel, US - West south central states:-:Pt:Ser:-


name: Respiratory allergen panel, US - West south central states


name: Respiratory allergen panel, US - Greater Ohio valley b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Greater Ohio valley b


name: Respiratory allergen panel, US - Northern midwest states b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Northern midwest states b


name: Respiratory allergen panel, US - Central midwest b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Central midwest b


name: Respiratory allergen panel, US - Great plains states b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Great plains states b


name: Respiratory allergen panel, US - Rocky mountain states b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Rocky mountain states b


name: Respiratory allergen panel, US - Inland northwest b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Inland northwest b


name: Respiratory allergen panel, US - Cascade Pacific northwest b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Cascade Pacific northwest b


name: Respiratory allergen panel, US - Intermountain west b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Intermountain west b


name: Respiratory allergen panel, US - AZ, Southeastern CA, Western NM:-:Pt:Ser:-


name: Respiratory allergen panel, US - AZ, Southeastern CA, Western NM


name: Respiratory allergen panel, US - Alaska b:-:Pt:Ser:-


name: Respiratory allergen panel, US - Alaska b


name: Respiratory allergen panel, US - Hawaii:-:Pt:Ser:-


name: PKHD1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: DCX gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ELN gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: EYA1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: FGFR2 gene+FGFR3 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Leukocytes^2nd specimen:PrThr:Pt:Stool:Ord:Methylene blue stain


name: MDCR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: GPR143 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: POLG gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SGCG gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CDKL5 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: TSC1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TSC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Glucose^20M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Immune complex.IgG:MCnc:Pt:Body fld:Qn:C1q binding assay


name: Norepinephrine^7th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Platelet aggregation.adenosine diphosphate induced:ACnc:Pt:PRP:Qn


name: Influenza virus A & B:Prid:Pt:XXX:Nom:Bioassay


name: PAH gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Streptococcus sp exoenzyme Ab:ACnc:Pt:Ser:Qn


name: Respiratory allergen panel, US - North Atlantic states c:-:Pt:Ser:-


name: Respiratory allergen panel, US - North Atlantic states c


name: Respiratory allergen panel, US - Intermountain west c:-:Pt:Ser:-


name: Respiratory allergen panel, US - Intermountain west c


name: Respiratory allergen panel, US - Puerto Rico:-:Pt:Ser:-


name: Respiratory allergen panel, US - Puerto Rico


name: Respiratory allergen panel, US - Coastal California:-:Pt:Ser:-


name: Respiratory allergen panel, US - Coastal California


name: Respiratory allergen panel, US - Greater Ohio valley c:-:Pt:Ser:-


name: Respiratory allergen panel, US - Greater Ohio valley c


name: Respiratory allergen panel, US - Northern midwest states c:-:Pt:Ser:-


name: Respiratory allergen panel, US - Northern midwest states c


name: Albumin:MRat:XXX:Urine:Qn:Detection limit <= 20 mg/L


name: Differential cell count method:Type:Pt:Bld:Nom


name: Trisomy 21 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency:Likelihood:Pt:^Fetus:Qn


name: Second trimester penta maternal screen:Imp:Pt:Ser/Plas:Nom


name: Respiratory syncytial virus Ab.IgG & IgM panel:ACnc:Pt:Ser:Qn


name: Respiratory syncytial virus Ab.IgG & IgM panel


name: Testosterone:MCnc:Pt:Ser/Plas:Qn:Detection limit <= 1.0 ng/dL


name: Testosterone.free:MCnc:Pt:Ser/Plas:Qn:Detection limit <= 1.0 ng/dL


name: Testosterone.free/Testosterone.total:MFr:Pt:Ser/Plas:Qn:Detection limit <= 1.0 ng/dL


name: Diazepam & Nordiazepam panel:-:Pt:Ser/Plas:Qn


name: PT & aPTT & Fibrinogen panel:-:Pt:PPP:Qn:Coag


name: Ribonucleoprotein extractable nuclear 52kD Ab:PrThr:Pt:Ser:Ord


name: Blood group antibody score:Score:Pt:Ser/Plas:Ord


name: Trisomy 21+Trisomy 18 risk:Likelihood:Pt:^Fetus:Qn


name: Eastern equine encephalitis virus Ab.IgG & IgM:Imp:Pt:CSF:Nom


name: Western equine encephalitis virus Ab.IgG & IgM:Imp:Pt:CSF:Nom


name: La Crosse virus Ab.IgG & IgM:Imp:Pt:CSF:Nom


name: Saint Louis encephalitis virus Ab.IgG & IgM:Imp:Pt:CSF:Nom


name: Epstein Barr virus Ab:Titr:Pt:Ser:SemiQn


name: Urea nitrogen^post dialysis/pre dialysis:MRto:Pt:Ser/Plas:Qn


name: Kanamycin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Western equine encephalitis virus Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel:-:Pt:^Patient:-


name: Census block group 1970&80&90:Arb:Pt:^Patient:Ord


name: First & Second trimester integrated maternal screen panel:-:Pt:^Patient:-


name: First trimester maternal screen with nuchal translucency panel:-:Pt:^Patient:-


name: Maternal screen clinical predictors panel:-:Pt:^Patient:-


name: Maternal screen clinical predictors panel


name: Fetal trisomy 21 risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Neural tube defect risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Second trimester quad maternal screen:Imp:Pt:Ser/Plas:Nar


name: Arbovirus Ab.IgG & IgM panel:-:Pt:Ser:-:IF


name: Arbovirus Ab.IgG & IgM panel:-:Pt:CSF:-:IF


name: Saint Louis encephalitis virus Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Herpes virus 8 DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Immunodeficiency follow-up panel:-:Pt:XXX:-:Flow cytometry


name: Glucose^2H post dose glucose:MCnc:Pt:Bld:Qn


name: Fractional excretion of sodium:Ratio:Pt:Urine+Ser/Plas:Qn


name: California encephalitis virus Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: California encephalitis virus Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: California encephalitis virus Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: California encephalitis virus Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: La Crosse virus Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel:-:Pt:^Patient:-


name: North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel


name: Saint Louis encephalitis virus Ab.IgM:PrThr:Pt:Body fld:Ord


name: Rickettsia rickettsii Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia rickettsii Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Rickettsia prowazekii Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Rickettsia prowazekii Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia parkeri Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia parkeri Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Rickettsia conorii Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Rickettsia conorii Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia akari Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Rickettsia akari Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia africae Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Rickettsia africae Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Kato Ab.IgM:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Kato Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Kato Ab.IgG:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Kato Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Karp Ab.IgM:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Karp Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Karp Ab.IgG:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Karp Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Orientia tsutsugamushi Gilliam Ab.IgG:Titr:Pt:Ser:SemiQn


name: Orientia tsutsugamushi Gilliam Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Herpes virus 8 Ab.IgM:Titr:Pt:Ser:SemiQn


name: Hepatitis B virus surface Ab.IgG:PrThr:Pt:Ser:Ord


name: Ehrlichia chaffeensis Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Ehrlichia chaffeensis Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 2 Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 2 Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 2 Ab.IgA:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 1 Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 1 Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 1 Ab.IgA:Titr:Pt:Body fld:SemiQn


name: Corynebacterium diphtheriae toxin Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Corynebacterium diphtheriae toxin Ab.IgG:ACnc:Pt:Ser:Qn


name: Coccidioides sp Ab:PrThr:Pt:Body fld:Ord


name: Clostridium tetani toxoid Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Clostridium tetani toxoid Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: California encephalitis virus Ab.IgM:Titr:Pt:CSF:SemiQn


name: California encephalitis virus Ab.IgG:Titr:Pt:CSF:SemiQn


name: California encephalitis virus Ab.IgG:ACnc:Pt:Ser:Qn


name: Bartonella vinsonii berkhoffii Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Bartonella vinsonii berkhoffii Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Bartonella vinsonii berkhoffii Ab.IgG:Titr:Pt:Ser:SemiQn


name: Bartonella vinsonii berkhoffii Ab.IgM:Titr:Pt:Ser:SemiQn


name: Bartonella quintana Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Bartonella quintana Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Bartonella henselae Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Bartonella henselae Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Bartonella elizabethae Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Bartonella elizabethae Ab.IgG:Titr:Pt:Body fld:SemiQn


name: Giardia lamblia+Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:Rapid, less than 30 minutes


name: Giardia lamblia+Cryptosporidium parvum Ag:PrThr:Pt:Stool:Ord:Rapid, less than 30 minutes


name: Patient symptoms^1.5H post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^1H post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^2.5H post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^2H post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^30M post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^3H post dose lactose PO:Imp:Pt:^Patient:Nar


name: Patient symptoms^pre dose lactose PO:Imp:Pt:^Patient:Nar


name: Alpha 1 antitrypsin phenotype:Imp:Pt:Ser/Plas:Nar


name: Alpha tocopherol & Beta+gamma tocopherol:Imp:Pt:Ser/Plas:Nar


name: Deprecated Amino acids [interpretation] in Serum or Plasma Narrative


name: Deprecated Amino acids [interpretation] in Urine Narrative


name: Beta-N-acetylhexosaminidase A & B:Imp:Pt:Bld:Nar


name: Cryoglobulin IgA & IgG & IgM:Imp:Pt:Ser:Nar


name: Fatty acids.very long chain pattern:Imp:Pt:Ser/Plas:Nar


name: Interpretation:Impression/interpretation of study:24 hours:Urine:Narrative:Immunofixation


name: Protein pattern:Impression/interpretation of study:24 hours:Urine:Narrative:Electrophoresis


name: Spermatozoa evaluation.cervical mucus penetration test:Imp:Pt:Semen:Nar


name: Spermatozoa evaluation.hamster ova penetration test:Imp:Pt:Semen:Nar


name: Neutrophil cytoplasmic Ab pattern:Imp:Pt:Ser:Nar:IF


name: Nuclear Ab pattern:Imp:Pt:Body fld:Nar:IF


name: Hemolytic disease of newborn screen:Imp:Pt:Bld:Nar


name: 15 minutes pre 100 ug luteinizing releasing hormone IV


name: 2.5 hours post dose luteinizing releasing hormone IV


name: 30 minutes pre dose propranolol+glucagon


name: Alpha-1-fetoprotein & Choriogonadotropin & Estriol.unconjugated


name: Nucleic acid amplification detection limit = 1.7 log copies/mL


name: Nucleic acid amplification detection limit = 2.6 log copies/mL


name: Nucleic acid amplification detection limit = 400 copies/mL


name: Nucleic acid amplification detection limit = 50 copies/mL


name: Nucleic acid amplification detection limit = 500 copies/mL


name: Deprecated 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)


name: Repair of cystocele and rectocele with graft or prosthesis


name: Repair of cystocele with graft or prosthesis


name: Anterior colporrhaphy (with urethrocele repair)


name: Repair of rectocele with graft or prosthesis


name: Vaginal construction with graft or prosthesis


name: Vaginal reconstruction with graft or prosthesis


name: Vaginal suspension and fixation with graft or prosthesis


name: Other operations on cul-de-sac with graft or prosthesis


name: Repair of vaginal enterocele with graft or prosthesis


name: Insertion of allogenic material or substance into vagina or cul-de-sac


name: Insertion of allograft into vagina or cul-de-sac


name: Insertion of autograft into vagina or cul-de-sac


name: Insertion of autologous material or substance into vagina or cul-de-sac


name: Insertion of heterograft into vagina or cul-de-sac


name: Insertion of xenogenic material or substance into vagina or cul-de-sac


name: Insertion of synthetic graft or prosthesis


name: Insertion of artificial tissue into vagina or cul-de-sac


name: Removal of pedicle screw(s) used in spinal fusion


name: Insertion or replacement of interspinous process device(s)


name: Insertion or replacement of interspinous process decompression device(s)


name: Insertion or replacement of interspinous process distraction device(s)


name: Revision of interspinous process device(s)


name: Repair of previously inserted interspinous process device(s)


name: Insertion or replacement of pedicle-based dynamic stabilization device(s)


name: Revision of pedicle-based dynamic stabilization device(s)


name: Repair of previously inserted pedicle-based dynamic stabilization device(s)


name: Insertion or replacement of facet replacement device(s)


name: Repair of previously inserted facet replacement device(s)


name: Insertion, replacement and revision of posterior spinal motion preservation device(s)


name: Insertion, replacement and revision of dynamic spinal stabilization device(s)


name: Removal of carotid sinus baroreflex activation device


name: Intra-operative coronary fluorescence vascular angiography


name: Intra-operative electron radiation therapy


name: Intra-operative electron radiation therapy using a mobile linear accelerator


name: Infusion of immunosuppressive antibody therapy


name: Infusion of polyclonal antibody therapy during induction phase of solid organ transplantation


name: Disruption of blood brain barrier via infusion [BBBD]


name: Infusion of substance to disrupt blood brain barrier


name: Hip bearing surface, metal-on-polyethylene


name: Hip bearing surface, metal-on-metal procedure NEC in ICD-9-CM


name: Hip bearing surface, ceramic-on-polyethylene


name: Partial pressure of brain oxygen (PbtO2) monitoring


name: Thoracoscopic partial excision of thymus


name: Other and unspecified thoracoscopic operations on thymus


name: Other and unspecified operations on thymus


name: Attachment of percutaneous abutment for prosthetic device


name: Attachment of percutaneous screw for prosthetic device


name: Thoracoscopic excision of lesion or tissue of lung


name: Thoracoscopic segmental resection of lung


name: Other and unspecified segmental resection of lung


name: Transthoracic needle biopsy of lung (TTNB)


name: Thoracoscopic drainage of pleural cavity


name: Stapled transanal rectal resection (STARR)


name: Leukocyte Migration Capillary Tube Technique


name: Amplified Fragment Length Polymorphism Analysis


name: Acoustic Radiation Force Impulse Imaging


name: Minority Health and Health Disparities Research and Education Act of 2000


name: United States Department of Homeland Security


name: United States Office of National Drug Control Policy


name: National Heart, Lung, and Blood Institute (U.S.)


name: National Human Genome Research Institute (U.S.)


name: National Institute on Alcohol Abuse and Alcoholism (U.S.)


name: National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.)


name: National Institute of Biomedical Imaging and Bioengineering (U.S.)


name: National Institute on Deafness and Other Communication Disorders (U.S.)


name: National Institute of Environmental Health Sciences (U.S.)


name: Biphasic Intermittent Positive Airway Pressure


name: Particle-Mediated Epidermal Delivery of DNA


name: Biphasic Continuous Positive Airway Pressure


name: platelet receptor for type III collagen, human


name: citric acid / gluconolactone / magnesium carbonate


name: Combined atrial switch and arterial switch operation (procedure)


name: Reconstruction of breast using transverse rectus abdominis myocutaneous flap


name: Induction of minimal sedation (procedure)


name: Hysterosalpingography with positive contrast


name: Trephines, Surgical, Eye, Corneoscleral (device)


name: Scissors, Surgical, Uterine, Parametrium/Hysterectomy


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zovia 1/35E 28 Day]


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zovia 1/50E 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Levora 0.15/30 28 Day]


name: {6 (ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet) / 10 (ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet) / 5 (ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Trivora 28 Day]


name: {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack [Activella 0.5/0.1 28 Day]


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Seasonique]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Junel 1/20 21 Day]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Junel 1.5/30 21 Day]


name: Sutures, Natural, Absorbable, Surgical Gut, Chromium-Treated


name: SODIUM CHLORIDE .9 mg in 1 mL INTRAVASCULAR INJECTION [SODIUM CHLORIDE]


name: Anastomosis of pancreatic duct to jejunum


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Loestrin 1/20 21 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Previfem 28 Day]


name: Airway patency esophageal device (procedure)


name: Mononuclear cell antigen, quantitative (eg, flow cytometry), not otherwise specified, each antigen


name: Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report


name: Dilated macular exam performed, including documentation of the presence or absence of macular thickening or hemorrhage and the level of macular degeneration severity (EC)


name: Optic nerve head evaluation performed (EC)


name: Complete physical skin exam performed (ML)


name: Documentation that an order was given to discontinue prophylactic antibiotics within 48 hours of surgical end time, cardiac procedures (PERI 2)


name: Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or given intraoperatively (PERI 2)


name: Documentation of order for prophylactic parenteral antibiotics to be given within 1 hour (if fluoroquinolone or vancomycin, 2 hours) prior to surgical incision (or start of procedure when no incision is required) (PERI 2)


name: Documentation that administration of prophylactic parenteral antibiotic was initiated within 1 hour (if fluoroquinolone or vancomycin, 2 hours) prior to surgical incision (or start of procedure when no incision is required) as ordered (PERI 2)


name: Documentation that order was given to discontinue prophylactic antibiotics within 24 hours of surgical end time, non-cardiac procedure (PERI 2)


name: Dysphagia screening conducted prior to order for or receipt of any foods, fluids, or medication by mouth (STR)


name: Measurement of the biomechanical properties of both corneas with interpretation and report


name: Osteochondral autograft(s), knee, open (eg, mosaicplasty) (includes harvesting of autograft[s])


name: Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)


name: Ascending aorta graft, with cardiopulmonary bypass with valve suspension, with coronary reconstruction and valve-sparing aortic root remodeling (eg, David Procedure, Yacoub Procedure)


name: Bypass graft, with vein; brachial-ulnar or -radial


name: BELT,SUPPORT 7IN RIGHT XX-LARGE NU-HOPE #6449 SP


name: DRESSING,AMERIGEL HYDROGEL 2IN X 2IN #5002


name: DRESSING,ODOR ABSORBENT 4IN X 4IN H#519904


name: DRESSING,ODOR ABSORBENT 6IN X 10IN H#519906


name: {1 (236 ML) (benzethonium chloride 1.3 MG/ML Medicated Liquid Soap) / 1 (78000 MG) (zinc oxide 100 MG/ML Topical Cream) } Pack


name: {1 (236 ML) (benzethonium chloride 1.3 MG/ML Medicated Liquid Soap) / 1 (72000 MG) (petrolatum 0.988 MG/MG Topical Ointment) } Pack


name: {1 (118 ML) (benzethonium chloride 1.3 MG/ML Medicated Liquid Soap) / 1 (92000 MG) (zinc oxide 306 MG/ML Topical Cream) } Pack


name: {1 (60 ML) (benzalkonium chloride 1 MG/ML Topical Solution [Pronto Plus Lice Egg Remover]) / 1 (60 ML) (piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML Medicated Shampoo [Pronto Plus]) } Pack [Pronto Plus Complete Lice Remover System]


name: {2 (levonorgestrel 0.75 MG Oral Tablet) } Pack [Plan B]


name: {1 (30 ML) (hydrocortisone 20 MG/ML Topical Lotion [Coraz]) / 1 (177 ML) (salicylic acid 20 MG/ML / sulfur 20 MG/ML Medicated Shampoo [Pulere]) } Pack [Coraz Lotion Kit]


name: {1 (20 ML) (iodine-131-tositumomab 0.1 MG/ML Injectable Solution) / 1 (16.1 ML) (tositumomab 14 MG/ML Injectable Solution) } Pack [Bexxar Dosimetric Packaging]


name: {2 (20 ML) (iodine-131-tositumomab 1.1 MG/ML Injectable Solution) / 2 (16.1 ML) (tositumomab 14 MG/ML Injectable Solution) } Pack [Bexxar Therapeutic Packaging]


name: Decompression - action (qualifier value)


name: Comprehensive prolonged new 180 minutes in-office homeopathic intake


name: Comprehensive prolonged new out-of-office 180 minutes homeopathic intake


name: Comprehensive prolonged new home visit 90 minutes homeopathic intake


name: Comprehensive prolonged new home visit 120 minutes homeopathic intake


name: Comprehensive prolonged new home visit 150 minutes homeopathic intake


name: Comprehensive prolonged new home visit 180 minutes homeopathic intake


name: Non-specified HCPCS II speech and/or hearing therapy service or procedure reference code no charge


name: Bombyx processionea (homeopathic preparation)


name: Germanium metallicum homeopathic preparation


name: Artemisia abrotanum (homeopathic remedy)


name: Astacus fluviatilis (homeopathic remedy)


name: Hydrophis cyanocinctus (homeopathic remedy)


name: Oncorhynchus tshawytscha (homeopathic remedy)


name: Sequoia sempervirens (homeopathic remedy)


name: chlorophyllin copper complex / papain / urea


name: CitraNatal DHA, Prenatal Multivitamins with Folic Acid 1 mg oral kit


name: Heparin Lock Flush, 2 units/mL intravenous solution


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tilia Fe]


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tri-Legest 28 Day]


name: {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack [VisRx Dosepack 10]


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {28 (drospirenone 0.5 MG / estradiol 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {6 (ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet) / 10 (ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet) / 5 (ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {11 (varenicline 0.5 MG Oral Tablet) / 42 (varenicline 1 MG Oral Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {56 (varenicline 1 MG Oral Tablet) } Pack


name: {15 (estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (estradiol 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {10 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 11 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (inert ingredients 1 MG Oral Tablet) / 21 (mestranol 0.05 MG / norethindrone 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack


name: SLC35A1, 2-BP DEL, 277G AND 281C, AND 147T-C


name: FOXL2, 15-BP DUP, NT684, ALANINE TRACT EXPANSION


name: STAT5B, 1-BP DEL, EXON 13/INTRON 13 JUNCTION


name: CHIT1, GLY354ARG, LEU385LEU, AND 4-BP DEL


name: Myringotomy and insertion of tympanic ventilation tube


name: Esophagus (including hiatus hernia) operations NOS (procedure)


name: Insertion of catheter into urinary bladder


name: Blood ketone test or reagent strip, each


name: Cervical traction device, with inflatable air bladder(s)


name: Manual wheelchair accessory, gear reduction drive wheel, each


name: Manual wheelchair accessory, wheel braking system and lock, complete, each


name: Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware


name: Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each


name: Power wheelchair accessory, lithium-based battery, each


name: Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes


name: Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes


name: Left ventricular ejection fraction (lvef) not performed or documented


name: Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy


name: Lower extremity neurological exam performed and documented


name: Lower extremity neurological exam not performed


name: Footwear evaluation performed and documented


name: Clinician documented that patient was not an eligible candidate for footwear evaluation measure


name: Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)


name: Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)


name: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed


name: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)


name: ONCOLOGY; DISEASE STATUS; INVASIVE FEMALE BREAST CANCER (DOES NOT INCLUDE DUCTAL CARCINOMA IN SITU); ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA; HORMONE-REFRACTORY/ANDROGEN-INDEPENDENT (E.G., RISING PSA ON ANTI-ANDROGEN THERAPY OR POST-ORCHIECTOMY); CLINICAL METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; STAGE I, II AT DIAGNOSIS, NOT RELAPSED, NOT REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; STAGE III, IV, NOT RELAPSED, NOT REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, TRANSFORMED FROM ORIGINAL CELLULAR DIAGNOSIS TO A SECOND CELLULAR CLASSIFICATION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; RELAPSED/REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; DIAGNOSTIC EVALUATION, STAGE NOT DETERMINED, EVALUATION OF POSSIBLE RELAPSE OR NON-RESPONSE TO THERAPY, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours


name: Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment


name: Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric


name: Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric


name: Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric


name: Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric


name: Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined


name: Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined


name: Physician management of patient home care, standard monthly case rate (per 30 days)


name: Physician management of patient home care, hospice monthly case rate (per 30 days)


name: Physician management of patient home care, episodic care monthly case rate (per 30 days)


name: Physician visit at member's home, outside of a capitation arrangement


name: Nurse practitioner visit at member's home, outside of a capitation arrangement


name: Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral


name: Breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral


name: Genetic testing for amyotrophic lateral sclerosis (als)


name: Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit


name: Astigmatism correcting function of intraocular lens


name: Tissue marker, implantable, any type, each


name: Continent device, stoma absorptive cover for continent stoma


name: Adhesive bandage, first-aid type, any size, each


name: COMBINATION ORAL/NASAL MASK, USED WITH CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE, EACH


name: Oral cushion for combination oral/nasal mask, replacement only, each


name: Nasal pillows for combination oral/nasal mask, replacement only, pair


name: External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories


name: Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply


name: Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system


name: Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system


name: Foot pressure off loading/supportive device, any type, each


name: Injection, gadoteridol, (prohance multipack), per ml


name: Injection, gadobenate dimeglumine (multihance), per ml


name: Injection, gadobenate dimeglumine (multihance multipack), per ml


name: Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml


name: Gastrostomy/jejunostomy tube, standard, any material, any type, each


name: Gastrostomy/jejunostomy tube, low-profile, any material, any type, each


name: Pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of chemotherapy (ONC)


name: Pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of radiation therapy (onc)


name: C Codes - CMS Hospital Outpatient System


name: Temporary National Codes Established by Medicaid


name: Brachytherapy source, stranded, iodine-125, per source


name: Brachytherapy source, non-stranded, iodine-125, per source


name: Brachytherapy source, stranded, palladium-103, per source


name: Brachytherapy source, non-stranded, palladium-103, per source


name: Brachytherapy source, stranded, cesium-131, per source


name: Brachytherapy source, stranded, not otherwise specified, per source


name: Brachytherapy source, non-stranded, not otherwise specified, per source


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report


name: Microporous collagen implantable tube (neuragen nerve guide), per centimeter length


name: Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length


name: Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple


name: Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy


name: Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy


name: Erythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy


name: Partial credit received for replaced device


name: Dmepos item subject to dmepos competitive bidding program number 1


name: Dmepos item subject to dmepos competitive bidding program number 2


name: Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item


name: Dmepos item subject to dmepos competitive bidding program number 3


name: Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service


name: Dmepos item subject to dmepos competitive bidding program number 4


name: Dmepos item subject to dmepos competitive bidding program number 5


name: Investigational clinical service provided in a clinical research study that is in an approved clinical research study


name: Routine clinical service provided in a clinical research study that is in an approved clinical research study


name: Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress


name: Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress


name: Tempo brand of antacid Reformulated Feb 2009


name: Other current diagnoses & ICD9 codes (quarterly)


name: Outpatient encounter-level information section:-:Pt:^Patient:Set:HIV-ART


name: Antiretroviral therapy status section:-:Pt:^Patient:Set:HIV-ART


name: HIV care & family status section:-:Pt:^Patient:Set:HIV-ART


name: Number of hospital D since last outpatient visit:Num:Pt:^Patient:Qn:Reported


name: Evidence of tuberculosis resistance:Find:Pt:^Patient:Nom:Reported


name: human immunodeficiency virus confirmation facility


name: Institutional entry point HIV Rx:Type:Pt:Facility:Nom:Reported


name: HIV Rx prior clinic transferred from:Addr:Pt:Facility:Nom:Reported


name: HIV Rx prior clinic transferred from:ID:Pt:Facility:Nom:Reported


name: District where patient entered HIV Rx:ID:Pt:^Patient:Nom:Reported


name: HIV Rx prior to enrollment:Type:Pt:^Patient:Nom:Reported


name: Reason medically eligible for HIV Rx:Find:Pt:^Patient:Nom:Reported


name: Date eligible and selected to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date eligible and selected to start HIV Rx


name: Date original clinic HIV Rx start:Date:Pt:^Patient:Qn:Reported


name: Date original clinic human immunodeficiency virus Rx start


name: Date lost to HIV Rx follow-up:Date:Pt:^Patient:Qn:Reported


name: Date lost to human immunodeficiency virus Rx follow-up


name: Date lost to HIV Rx therapy:Date:Pt:^Patient:Qn:Reported


name: Date lost to human immunodeficiency virus Rx therapy


name: Current HIV Rx therapy duration:Time:Pt:^Patient:Qn:Computed


name: Isoniazid therapy start date:Date:Pt:^Patient:Qn:Reported


name: Tuberculosis treatment start date:Date:Pt:^Patient:Qn:Reported


name: Reason for discontinuation of anti-infective phrophylaxis medication:Type:Pt:^Patient:Nom:Reported


name: HIV ART medication dose number taken/Medication dose number prescribed:NFr:Pt:^Patient:Qn:Reported


name: HIV ART medication dose number taken/Medication dose number prescribed


name: Degree of adherence to co-trimoxazole:Find:Pt:^Patient:Ord:Reported


name: Degree of adherence to anti-retroviral drug regimen:Find:Pt:^Patient:Ord:Reported


name: Reason for missing HIV Rx administration schedule:Find:Pt:^Patient:Nom:Reported


name: HIV Rx clinic transferred to:Addr:Pt:Facility:Nom:Reported


name: HIV Rx clinic transferred to:ID:Pt:Facility:Nom:Reported


name: Date dropped from HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date dropped from human immunodeficiency virus Rx


name: HIV ART medication dose number taken/Medication dose number prescribed:NFr:Pt:^Patient:Qn:MEMS Cap


name: HIV ART actual prescription fills number/Ideal prescription fills number:NFr:Pt:^Patient:Qn:Pharmacy records


name: HIV ART actual prescription fills number/Ideal prescription fills number


name: human immunodeficiency virus ART medication


name: {HIV ART medication} doses missed yesterday:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 2D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 3D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 4D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: Date of last day of MDS observation period


name: Medicaid resident liability or Medicare copayment


name: Alterability of physically abusive behavioral symptoms


name: Alterability of socially inappropriate or disruptive behavioral symptoms


name: Other current or more detailed diagnoses & ICD9 codes


name: Plate guard, stabilized built-up utensil, etc.


name: Training in skills required to return to the community


name: Nutrition or hydration intervention to manage skin problems


name: Application of dressings (with or without topical medications) other than to feet


name: Application of ointments or medications other than to feet


name: Application of dressings (foot) - with or without topical medications


name: Special behavior symptom evaluation program


name: Through D 15, provide an estimate of the number of D when at least 1 therapy service can be expected to have been delivered


name: Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free:MRto:24H:Urine:Qn


name: Beta F1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Papova virus SV40 DNA:NCnc:Pt:Stool:Qn:Probe.amp.tar


name: Parvovirus B19 DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Parvovirus B19 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Aspergillus sp Ab:PrThr:Pt:CSF:Ord:Immune diffusion


name: Herpes simplex virus 1+2 Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: 11-Dehydro thromboxane beta 2/Creatinine:MRto:Pt:Urine:Qn


name: FBN1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Reason for stopping HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Date determined medically eligible to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date determined medically eligible and ready to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Medication or other side effects associated with HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Severity of side effect to HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Symptom, diagnosis, or opportunistic infection related to HIV Rx:Type:Pt:^Patient:Nom:Reported


name: 11-Deoxycortisol^2H post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Muscle sarcolemma Ab:Titr:Pt:Plr fld:SemiQn:IF


name: ATN1 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: ATN1 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: FXN gene allele 1.GAA repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: FXN gene allele 2.GAA repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HTT gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HTT gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: Lymphocyte proliferation.100 umol beryllium stimulation^6D post incubation:Ratio:Pt:Bld:Qn


name: Arterial-mixed venous oxygen saturation difference:MFr:Pt:Bld:Qn


name: Arterial-mixed venous oxygen saturation difference


name: Arterial-venous oxygen saturation difference:MFr:Pt:Bld:Qn


name: Arterial-venous oxygen saturation difference


name: Iron & Iron binding capacity panel:-:Pt:Ser/Plas:Qn


name: Cholesterol.in IDL+Cholesterol.in VLDL 3:MCnc:Pt:Ser/Plas:Qn


name: Varicella zoster virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Alpha synuclein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Androgen receptor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Annexin 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Alzheimer precursor protein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Beta catenin Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: IgG subclass 4 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cyclooxygenase 2 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Herpes virus 8 latent nuclear Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Vascular endothelial growth factor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Glucose tolerance^post 75 g glucose PO:Imp:Pt:Ser/Plas:Nar


name: Glucose tolerance^post 100 g glucose PO:Imp:Pt:Ser/Plas:Nar


name: Hepatitis E virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldCoA:Qn


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldCoV:Qn


name: Oxygen^^adjusted to patient's actual temperature:PPres:Pt:BldCoA:Qn


name: Oxygen^^adjusted to patient's actual temperature:PPres:Pt:BldCoV:Qn


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldCoA:SemiQn


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldCoV:SemiQn


name: Neural tube defect risk:Likelihood:Pt:^Population:Qn


name: Coagulation surface induced.factor substitution^2H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^1H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^after addition of normal plasma 1H post incubation separate tubes:Time:Pt:PPP:Qn:Coag


name: Hepatitis C virus core Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord


name: Herpes simplex virus 1+2 Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Snowshoe hare virus Ab.Neut:PrThr:Pt:XXX:Ord:Neut


name: Advanced oxidation protein products:SCnc:Pt:Ser/Plas:Qn


name: Basal metabolic rate index:ACnc:Pt:^Patient:Qn


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (MDRD)/1.73 sq M among female population


name: Glomerular basement membrane Ab:ACnc:Pt:Ser:Qn


name: Transforming growth factor beta 1:MCnc:Pt:Ser/Plas:Qn


name: COL5A1 gene+COL5A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SMN1 gene+SMN2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: (Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Mahogany wood dust Ab.IgE:ACnc:Pt:Ser:Qn


name: Colorado tick fever virus Ab.Neut:PrThr:Pt:XXX:Ord:Neut


name: Calcitonin Calcium & Pentagastrin challenge panel:-:Pt:Ser/Plas:Qn


name: Calcitonin Calcium & Pentagastrin challenge panel


name: Calcitonin^10M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^5M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^2M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^1M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^pre 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Influenza virus A Ab.Neut:Prid:Pt:Ser:Nom:Neut


name: Influenza virus A Ag:Prid:Pt:Isolate:Nom


name: Influenza virus A.adamantane resistance:PrThr:Pt:Isolate:Ord:Phenotyping


name: Influenza virus A.adamantane resistance:PrThr:Pt:Isolate:Ord


name: Influenza virus A.adamantane resistant RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H1 Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A matrix protein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Referral lab test identifier and name:ID:Pt:Referral lab test:Nom


name: Trisomy 18 risk cutoff:Find:Pt:^Fetus:Qn


name: Trisomy 21 risk cutoff:Find:Pt:^Fetus:Qn


name: Neural tube defect risk cutoff:Find:Pt:^Fetus:Qn


name: Protein C/Coagulation factor X:MRto:Pt:PPP:Qn


name: Protein S Ag/Coagulation factor X Ag:MRto:Pt:PPP:Qn:Coag


name: SCA1 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA1 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA10 gene allele 1.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA10 gene allele 2.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA2 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SOD1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Listeria sp Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Parainfluenza virus Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points:Arb:Pt:Bone mar:Ord:Molgen


name: t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points:Arb:Pt:Bone mar:Ord:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript:NCnc:Pt:Bld/Tiss:Qn:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript:PrThr:Pt:Bone mar:Ord:Molgen


name: Androstenedione^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^3H post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^2H post XXX challenge:CCnc:Pt:Plas:Qn


name: Vasopressin^30M post XXX challenge:MCnc:Pt:Plas:Qn


name: BK virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: JC virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Pneumocystis jirovecii DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Toxoplasma gondii DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Toxoplasma gondii DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Platelet aggregation.ristocetin induced^1800 ug/mL:RelACnc:Pt:PRP:Qn


name: Microbiology section:-:-:^FDA package insert:Nar


name: BCR-ABL1 b2a2 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: BCR-ABL1 b3a2 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Hepatitis B virus surface Ab Actual/Negative control:RelACnc:Pt:Ser/Plas:Qn


name: Hepatitis B virus surface Ab Actual/Negative control


name: BCR-ABL1 e1a1 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Calcium oxalate dihydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy


name: Calcium oxalate monohydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy


name: CMT demyelinating gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Erythrocyte clumps:Naric:Pt:Urine sed:Qn:Automated count


name: MYOC gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.right:Doc:MG


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.left:Doc:MG


name: View runoff^WO & W contrast IA:Find:Pt:Lower extremity>Femoral artery:Doc:RF.angio


name: Influenza virus A H16 Ab:Titr:Pt:Ser:SemiQn:HAI


name: Influenza virus A H1 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H1 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H3 Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A H3 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H5 Ab:PrThr:Pt:Ser:Ord


name: Influenza virus A H5 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H7 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H9 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A hemagglutinin type RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus B Ab:PrThr:Pt:Ser:Ord:IA


name: Influenza virus B Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus B RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus B RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus A & B RNA:Prid:Pt:Isolate:Nom:Probe.amp.tar


name: Influenza virus:Prid:Pt:XXX:Nom:Shell vial culture


name: Date and time of pheresis procedure:TmStp:Pt:^Patient:Qn


name: Newborn screening recommended follow-up:Imp:Pt:^Patient:Nom


name: Date referral lab test sent:TmStp:XXX:Referral lab test:Qn


name: Referral lab test method:Type:Pt:Referral lab test:Nar


name: Holoprosencephaly gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Troponin I.cardiac:MCnc:Pt:Ser/Plas:Qn:Detection limit <= 0.01 ng/mL


name: Epstein Barr virus band pattern:Imp:Pt:XXX:Nar:IB


name: Multisection^at rest+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion^W adenosine+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion+wall motion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Views GE 6:Find:Pt:Lower extremity.bilateral>Ankle:Doc:XR


name: Views limited^W I-131 MIBG IV:Find:Pt:XXX:Doc:NM


name: Second trimester triple maternal screen:Imp:Pt:Ser/Plas:Nar


name: Alpha-1-Fetoprotein multiple of the median cutoff:MoM:Pt:Ser/Plas:Qn


name: Alpha-1-Fetoprotein multiple of the median cutoff


name: First & Second trimester integrated maternal screen:Imp:Pt:^Patient:Nom


name: First trimester maternal screen with nuchal translucency:Imp:Pt:^Patient:Nar


name: Bacterial susceptibility panel:-:Pt:Isolate:OrdQn:Gradient strip


name: Calcidiol & Calciferol panel:-:Pt:Ser/Plas:-


name: Hepatitis B virus DNA:LaCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus genotype:Prid:Pt:Tiss:Nom:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: SCA2 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: MJD gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: MJD gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: CACNA1A gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: CACNA1A gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA7 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA7 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HIV protease gene mutations:-:Pt:Isolate:-:Genotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel


name: HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV nucleoside reverse transcriptase susceptibility panel


name: HIV reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV reverse transcriptase susceptibility panel


name: HIV protease gene mutations:-:Pt:Isolate:-:Phenotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: HIV reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: Lymphocyte proliferation.100 umol beryllium stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.10 umol beryllium stimulation^5D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.10 umol beryllium stimulation


name: Lymphocyte proliferation.10 umol beryllium stimulation^7D post incubation:ACnc:Pt:Bld:Qn


name: Lymphocyte proliferation.1 umol beryllium stimulation^5D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.1 umol beryllium stimulation


name: Lymphocyte proliferation.1 umol beryllium stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: CPT2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Lymphocyte proliferation.phytohemagglutinin stimulation^3D post incubation:Ratio:Pt:Bld:Qn


name: ERBB2 gene copy number/Chromosome 17 copy number:NRto:Pt:Tiss:Qn:FISH


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:Bld:SemiQn


name: SH3TC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: LMNA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ARSA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: KCNQ2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TTR gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Deprecated Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy


name: Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 5 IU/mL


name: Hepatitis D virus Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Coagulation factor VII Ag actual/Normal:RelACnc:Pt:PPP:Qn:IA


name: FH gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: POU3F4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ABCB4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hydrogen/Expired gas^1.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^2H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^3H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Fetal lung maturity panel:-:Pt:Amnio fld:Qn


name: Cytokeratin 19 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin 5 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Galectin 3 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Granzyme B Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Helicobacter pylori Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Serotonin release.heparin.low molecular weight interpretation:Imp:Pt:Ser:Nom


name: Serotonin release.heparin.low molecular weight interpretation


name: Serotonin release.heparin.low molecular weight panel:-:Pt:Ser:-


name: Serotonin release.heparin.low molecular weight panel


name: Serotonin release.heparin.porcine & low molecular weight panel:-:Pt:Ser:-


name: Serotonin release.heparin.porcine & low molecular weight panel


name: Guaranteed analysis of feed section:-:-:^FDA product label:Nar


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldC+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldA+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldMV+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldV+Inhl gas:Qn


name: CMT demyelinating gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Taenia solium larva Ab:ACnc:Pt:CSF:Qn:IA


name: 2-Hydroxyestrone & 16-Alpha hydroxyestrone panel:-:Pt:Ser/Plas:-


name: 2-Hydroxyestrone & 16-Alpha hydroxyestrone panel


name: Protein fractions.oligoclonal bands:Num:Pt:CSF:Qn:Isoelectric focusing


name: G6PC gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coagulation factor VIII activity actual/Normal:RelACnc:Pt:PPP:Qn:Chromo


name: Herpes simplex virus 1 DNA:NCnc:Pt:Body fld:Qn:Probe.amp.tar


name: Herpes simplex virus 1 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Body fld:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Borrelia burgdorferi 18_20kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Hepatitis B virus codon 173:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 180:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 181:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 204:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 236:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 80:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus resistance panel:-:Pt:Isolate:-:Genotyping


name: Lymphocyte proliferation.tetanus toxoid stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.beryllium stimulation panel:-:Pt:Bld:-


name: Lymphocyte proliferation.beryllium stimulation panel


name: Adenosine monophosphate.cyclic/Creatinine^1st specimen post XXX challenge:Ratio:Pt:Urine:Qn


name: Dehydroepiandrosterone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^pre dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Human papilloma virus DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Somatotropin^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Histoplasma capsulatum M Ab:PrThr:Pt:CSF:Ord


name: Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda:MRto:24H:Urine:Qn


name: Japanese encephalitis virus Ab:Titr:Pt:CSF:SemiQn


name: Legionella pneumophila 1+2+3+4+5+6 Ab.IgM:PrThr:Pt:Ser:Ord


name: Lymphocyte proliferation.10 umol beryllium stimulation^6D post incubation:Ratio:Pt:WBC:Qn


name: Lymphocyte proliferation.concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation.concanavalin A stimulation


name: Lymphocyte proliferation.pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation.pokeweed mitogen stimulation


name: Glucose-6-Phosphate dehydrogenase:CCnt:Pt:RBC:Qn:Glock & McLean


name: Serum/Plasma+Pleural fluid (thoracentesis fld)


name: Lactate dehydrogenase.plr fld/Lactate dehydrogenase.serum:RelRto:Pt:Ser/Plas+Plr fld:Qn


name: Observation^^adjusted to pH 7.4:SpGrav:Pt:Urine:Qn


name: Urate renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn


name: Cortisol^1H post 250 ug corticotropin IM:SCncDiff:Pt:Ser/Plas:Qn


name: Cortisol^30M post 250 ug corticotropin IM:SCncDiff:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi 31kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 31kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Herpes simplex virus 1 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Borrelia burgdorferi 83_93kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Hydrogen/Expired gas^30M post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Indirect antiglobulin test.polyspecific reagent:PrThr:Pt:Ser/Plas:Ord:PEG


name: Hydrogen/Expired gas^2.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: West Nile virus Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord


name: Hepatitis C virus RNA panel:-:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Fractional excretion of phosphate:Ratio:XXX:Urine+Ser/Plas:Qn


name: Fatty acids.very long chain.C24:0/Creatinine:SRto:Pt:Urine:Qn


name: Fatty acids.very long chain.C24:0/Creatinine


name: Urea renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^45M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Ketosteroids^2D post dose dexamethasone:MCnc:Pt:Urine:Qn


name: 17-Hydroxypregnenolone^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^pre 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^45M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Adenine phosphoribosyltransferase:CCnt:Pt:Amnio fld cells:Qn


name: Aldosterone^pre 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^30M post 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript:LnRto:Pt:Bld/Tiss:Qn:Molgen


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Cystatin C-based formula/1.73 sq M


name: Respiratory pathogens DNA & RNA 12a panel:-:Pt:XXX:-:Probe.amp.tar


name: Collection interval from baseline:Time:Pt:^Specimen:Qn


name: Oval fat bodies (globules):PrThr:Pt:Urine:Ord:Computer assisted


name: Leukocyte clumps:Naric:Pt:Urine sed:Qn:Automated count


name: Mixed cellular casts:PrThr:Pt:Urine:Ord:Computer assisted


name: 17-Ketosteroids^post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketosteroids^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketosteroids^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxypregnenolone^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^1st specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^2nd specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^3rd specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^4th specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^5th specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Deprecated Renal function panel & Glomerular filtration rate.predicted


name: Renal function panel & Glomerular filtration rate.predicted


name: 17-Ketosteroids^post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Ketosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 2-Dechloroethylifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^5D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: Deprecated 3-Hydroxytetradecanoylcarnitine (C14-OH) [Molecules/volume] in Serum or Plasma


name: 3-Dechloroethylifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^6D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^5D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: Respiratory syncytial virus Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: SLC6A4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Alpha-beta crystallin Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: carBAMazepine & metabolites panel:-:Pt:Ser/Plas:-


name: Deprecated Cholesterol [Mass/volume] in blood


name: Parvovirus B19 DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Parvovirus B19 DNA:PrThr:Pt:Bone mar:Ord:Probe.amp.tar


name: Parvovirus B19 DNA:PrThr:Pt:Amnio fld:Ord:Probe.amp.tar


name: Platelet glycoprotein IIb-IIIa Ab:PrThr:Pt:Ser:Ord


name: Eosinophils.band form/Cells:NFr:Pt:Bone mar:Qn:Manual count


name: Lupus anticoagulant neutralization.dilute phospholipid actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Lupus anticoagulant neutralization.dilute phospholipid actual/Normal


name: von Willebrand factor.collagen binding activity actual/Normal:RelRto:Pt:PPP:Qn:IA


name: von Willebrand factor.collagen binding activity/von Willebrand factor Ag:Ratio:Pt:PPP:Qn:IA


name: von Willebrand factor.collagen binding activity/von Willebrand factor Ag


name: Creatinine dialysis fluid clearance/1.73 sq M:ArVRat:Pt:Dial fld+Ser/Plas:Qn


name: Creatinine renal clearance/1.73 sq M.predicted.female:ArVRat:Pt:Ser/Plas:Qn:Cockcroft-Gault formula, BSA formula


name: Creatinine renal clearance/1.73 sq M.predicted.female


name: Creatinine renal clearance/1.73 sq M.predicted.male:ArVRat:Pt:Ser/Plas:Qn:Cockcroft-Gault formula, BSA formula


name: Creatinine renal clearance/1.73 sq M.predicted.male


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (Schwartz)/1.73 sq M


name: Observation:Prid:Pt:Bronchial brush:Nom:Cyto stain.thin prep


name: Coagulation factor II circulating inhibitor:PrThr:Pt:PPP:Ord


name: Coagulation factor II circulating inhibitor


name: Coagulation surface induced circulating inhibitor:PrThr:Pt:PPP:Ord


name: Coagulation surface induced circulating inhibitor


name: Molecular diagnostic major findings for display:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Molecular diagnostic overall interpretation:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Molecular diagnostic overall interpretation


name: Body temperature^post transfusion reaction:Temp:Pt:^Patient:Qn


name: Blood group antibody titered:Prid:Pt:Ser/Plas:Nom


name: Blood pressure systolic & diastolic^post transfusion:Pres:Pt:Arterial system:Qn


name: Blood pressure systolic & diastolic^pre transfusion:Pres:Pt:Arterial system:Qn


name: Patient symptoms^post transfusion reaction:Imp:Pt:^Patient:Nar


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid:Ratio:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid


name: Corticotropin^pre 1 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^post 1 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Cortisol^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^post 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^post 2 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^pre 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Plas:Qn


name: Corticotropin^post 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Plas:Qn


name: Cortisol^pre 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^20M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^40M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1H post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^20M post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^40M post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^1H post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Cortisol^30M pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^20M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M pre dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^20M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Plasma cells/Leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: (Views) + (view AP^W standing):Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt:Find:Pt:Abdomen>Portal vein+Hepatic vein:Doc:RF.angio


name: Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt


name: Thyrotropin^20M post dose TRH:ACnc:Pt:Ser/Plas:Qn


name: Bacterial susceptibility panel:-:Pt:Isolate:OrdQn:Agar diffusion


name: Eastern equine encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Urinalysis microscopic panel:NCnc:Pt:Urine:Qn:Automated count


name: Urinalysis dipstick panel:-:Pt:Urine:-:Test strip.automated


name: OTC - Keep out of reach of children section:-:-:^FDA product label:Nar


name: OTC - Keep out of reach of children section


name: OTC - Stop use section:-:-:^FDA product label:Nar


name: OTC - When using section:-:-:^FDA product label:Nar


name: OTC - Ask doctor or pharmacist section:-:-:^FDA product label:Nar


name: OTC - Ask doctor section:-:-:^FDA product label:Nar


name: OTC - Do not use section:-:-:^FDA product label:Nar


name: VFD Type C medicated feed animal drug label:-:-:^FDA product label:Nar


name: VFD Type C medicated feed animal drug label


name: VFD Type B medicated feed animal drug label:-:-:^FDA product label:Nar


name: VFD Type B medicated feed animal drug label


name: OTC Type C medicated feed animal drug label:-:-:^FDA product label:Nar


name: OTC Type C medicated feed animal drug label


name: OTC Type B medicated feed animal drug label:-:-:^FDA product label:Nar


name: OTC Type B medicated feed animal drug label


name: VFD Type A medicated article animal drug label:-:-:^FDA product label:Nar


name: VFD Type A medicated article animal drug label


name: OTC Type A medicated article animal drug label:-:-:^FDA product label:Nar


name: OTC Type A medicated article animal drug label


name: OTC animal drug label:-:-:^FDA product label:Nar


name: Prescription animal drug label:-:-:^FDA product label:Nar


name: Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel:-:Pt:Ser/Plas:-


name: Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel


name: Adenosine monophosphate.cyclic stimulation panel:-:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic stimulation panel


name: Glucose tolerance gestational panel:-:Pt:Urine+Ser/Plas:-


name: Glucose screen gestational panel:-:Pt:Urine+Ser/Plas:-


name: Lactose challenge panel:-:Pt:Exhl gas:Qn


name: Triple bolus stimulation panel:-:Pt:Ser/Plas:Qn


name: Glucose tolerance 3H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 4H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 5H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 6H panel:-:-:Ser/Plas:Qn


name: Hydrogen/Expired gas^pre XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^4H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Neisseria meningitidis serogroups Ag panel:-:Pt:XXX:-:LA


name: Neisseria meningitidis serogroups Ag panel


name: Glucose tolerance 3H gestational panel:-:-:Ser/Plas:Qn


name: Alpha-1-Fetoprotein^^adjusted for multiple gestations:MoM:Pt:Ser/Plas:Qn


name: Chlamydophila pneumoniae Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom


name: Hydrogen/Expired gas^3.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^4.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^5.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^6H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: HTT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: AS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HIV 1 RNA panel:-:Pt:CSF:Qn:Probe.amp.tar


name: Ova & parasites:Prid:Pt:Bld/Tiss:Nom:Wright stain


name: DMD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Immunoglobulin heavy chain gene rearrangements:Find:Pt:Bld/Tiss:Nar:Molgen


name: Liver kidney microsomal Ab.IgG:Titr:Pt:Ser:SemiQn


name: Gentamicin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Cefepime:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Cefotaxime:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Coagulation factor XIII inhibitor:PrThr:Pt:PPP:Ord:Chromo


name: Bixa orellana seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:Anal:Ord:Probe.amp.sig


name: Latex recombinant (rHev b) 1 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 11 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 6.01 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 6.02 Ab.IgE:ACnc:Pt:Ser:Qn


name: Lupinus albus seed Ab.IgE:ACnc:Pt:Ser:Qn


name: (Arachis hypogaea+Cow milk+Egg white+Mustard) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Actinidia chinensis+Beef+Pandalus borealis+Sesamum indicum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Actinidia chinensis+Corylus avellana+Musa spp+Pandalus borealis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Corylus avellana+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Allium cepa+Allium sativum+Sesamum indicum+Yeast) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Herpes simplex virus 1 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes simplex virus 1 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Nuclear matrix protein 22:PrThr:Pt:Urine:Ord


name: Semen analysis post vasectomy panel:-:Pt:Semen:-


name: First trimester maternal screen with nuchal translucency:Imp:Pt:^Patient:Nom


name: Thyroxine binding protein pattern:Imp:Pt:Ser/Plas:Nom:Electrophoresis


name: Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab:PrThr:Pt:Ser:Ord


name: Deprecated 11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine


name: 11-Dehydro thromboxane beta 2/Creatinine


name: Plasmodium sp lactate dehydrogenase:Prid:Pt:Bld:Nom


name: Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Parainfluenza virus 1+2+3 Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Influenza virus A+B Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Influenza virus A.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord:Phenotyping


name: Influenza virus A nucleoprotein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A non-structural protein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase A RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase B1 cDNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase B2 RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus B Ab:Titr:Pt:Ser:SemiQn:HAI


name: Influenza virus susceptibility panel:-:Pt:Isolate:-


name: Influenza virus A polymerase RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord


name: Influenza virus.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord:Genotyping


name: 11-Deoxycortisol^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: VKORC1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Reticulum cell/Cells:NFr:Pt:Bone mar:Qn:Gomori stain


name: Serotonin release 100 IU/mL heparin.unfractionated:ACnc:Pt:Ser:Qn


name: Serotonin release 0.1 IU/mL heparin.unfractionated:ACnc:Pt:Ser:Qn


name: Serotonin release 100 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 0.1 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Safe handling warning section:-:-:^FDA product label:Nar


name: Environmental warning section:-:-:^FDA product label:Nar


name: Food safety warning section:-:-:^FDA product label:Nar


name: Information for owners or caregivers section:-:-:^FDA product label:Nar


name: Information for owners or caregivers section


name: Veterinary indications section:-:-:^FDA product label:Nar


name: Platelet factor 4 Ag:PrThr:Pt:PPP:Ord:IA


name: Glucose^15M post 0.1 U/kg insulin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral:Doc:CT


name: Herpes simplex virus 1 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Coagulation surface induced.lupus sensitive.factor substitution^1H post incubation after addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Ganglioside GD1a Ab.IgG/Ganglioside GD1a Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GD1a Ab.IgG/Ganglioside GD1a Ab.IgM


name: Ganglioside GD1b Ab.IgG/Ganglioside GD1b Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GD1b Ab.IgG/Ganglioside GD1b Ab.IgM


name: Asialoganglioside GM1 Ab.IgG/Asialoganglioside GM1 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Asialoganglioside GM1 Ab.IgG/Asialoganglioside GM1 Ab.IgM


name: Ganglioside GM1 Ab.IgG/Ganglioside GM1 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GM1 Ab.IgG/Ganglioside GM1 Ab.IgM


name: Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM


name: Ganglioside GQ1b Ab.IgG/Ganglioside GQ1b Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GQ1b Ab.IgG/Ganglioside GQ1b Ab.IgM


name: ABO & Rh group^post transfusion reaction:Type:Pt:Bld^Newborn:Nom


name: Primary reason for assessment:Type:Pt:^Patient:Nom:MDS.full


name: Hemoglobin pattern:Imp:Pt:Bld:Nom:Electrophoresis pH 6.0


name: XXX blood group Ab.IgM:Titr:Pt:Ser/Plas:SemiQn


name: Hepatitis B virus surface Ag:PrThr:Pt:Bld^Donor:Ord:Neut


name: Epstein Barr virus early diffuse Ab.IgG:ACnc:Pt:Ser:Qn


name: XXX blood group Ab:Titr:Pt:Ser/Plas:SemiQn:Antihuman globulin


name: Paragonimus sp Ab:Titr:Pt:Plr fld:SemiQn


name: Parainfluenza virus 1+2+3 Ab:Titr:Pt:Ser:SemiQn


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:Body fld:Qn


name: Mycobacterium sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Reasons for assessment (full):-:Pt:^Patient:Set


name: Platelet aggregation.adenosine diphosphate induced^20 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.adenosine diphosphate induced^2 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.adenosine diphosphate induced^4 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.collagen induced^190 ug/mL:PrThr:Pt:PRP:Ord


name: Indirect antiglobulin test.XXX reagent^post transfusion:PrThr:Pt:Ser/Plas:Ord


name: Indirect antiglobulin test.XXX reagent:PrThr:Pt:Ser/Plas:Ord


name: XXX blood group Ab.IgG:Titr:Pt:Ser/Plas:SemiQn


name: Cytology report:Find:Pt:Bronchial brush:Doc:Cyto stain


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldMV:SemiQn


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldMV:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:Bld+Inhl gas:Qn


name: BRCA1+BRCA2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HBB gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CFTR gene mutations tested for:Num:Pt:Bld/Tiss:Qn:Molgen


name: Leishmania donovani Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Leishmania tropica Ab.IgG & IgM:Imp:Pt:Ser:Nar


name: Direct antiglobulin test.XXX reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.XXX reagent^post transfusion:PrThr:Pt:RBC:Ord


name: Triticum aestivum native (nTri a) 19 Ab.IgE:ACnc:Pt:Ser:Qn


name: CD117 Ag:PrThr:Pt:Bone mar:Ord:Immune stain


name: CD15 Ag:PrThr:Pt:Bone mar:Ord:Immune stain


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG2:MCnc:Pt:Ser:Qn:IA


name: 17-Hydroxyprogesterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Testosterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre or post XXX challenge:SCnc:Pt:Plas:Qn


name: Cortisol^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: EPINEPHrine^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lactate^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Norepinephrine^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Calcitonin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Gastrin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^pre or post XXX challenge:MCnc:Pt:Plas:Qn


name: Somatotropin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Paragonimus sp Ab:Titr:Pt:Plr fld:SemiQn:IA


name: Coccidioides immitis Ab:Titr:Pt:Body fld:SemiQn


name: Epstein Barr virus early diffuse Ab:PrThr:Pt:CSF:Ord


name: Influenza virus A H16 Ab:Titr:Pt:Ser:SemiQn


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG2:MCnc:Pt:Ser:Qn


name: ABCB4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coccidioides sp Ab.IgM:PrThr:Pt:XXX:Ord:Immune diffusion


name: 10 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 2 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 5 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: after addition of normal plasma 1 hour post incubation separate tubes


name: pre 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: Anticoagulants, pro- and antifibrinolytics


name: Miscellaneous toxic small organic and inorganic molecules


name: Nucleic acid amplification detection limit = 5 iU/mL


name: {21 (ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) } Pack


name: BANDAGE TUBULAR ELASTIC PADDED LARGE C#154581


name: BANDAGE TUBULAR ELASTIC PADDED MEDIUM C#154580


name: BANDAGE TUBULAR ELASTIC PADDED SMALL C#154579


name: BANDAGE,ELASTIC,CONFORMING (MOLLELAST) 1.6IN X 4.4YD


name: BARRIER,ASSURA PEDIATRIC COLOPLAST #2182


name: BELT,ELASTIC 1.5IN WITH PLASTIC BUCKLES NU-HOPE #2610


name: BELT,ELASTIC 1IN WITH PLASTIC BUCKLE NU-HOPE #2600


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2663DC


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-H


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6604-P


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6604-PC


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-B


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-PC


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-SP


name: DRESSING,ACTICOAT ROPE 0.75IN X 12IN SN#20181


name: BELT,SUPPORT 9IN X-LARGE NU-HOPE #6643-SP


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR LARGE ATTENDS


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR MEDIUM ATTENDS


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR X-LARGE ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR LARGE ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR MEDIUM ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR X-LARGE ATTENDS


name: CATHETER FOLEY 2-WAY SPECIALTY 5CC BARD#0196SI16


name: CATHETER,EXTERNAL INTERMEDIATE FREEDOM CLEAR #5300/5330


name: CATHETER,EXTERNAL INTERMEDIATE FREEDOM CLEAR SS #5310


name: CATHETER,EXTERNAL LARGE FREEDOM CLEAR #5400/5430


name: CATHETER,EXTERNAL LARGE FREEDOM CLEAR SS #5410


name: CATHETER,EXTERNAL MEDIUM FREEDOM CLEAR #5200/5230


name: CATHETER,EXTERNAL MEDIUM FREEDOM CLEAR SS #5210


name: CATHETER,EXTERNAL SMALL FREEDOM CLEAR #5100/5130


name: CATHETER,EXTERNAL SMALL FREEDOM CLEAR SS #5110


name: CATHETER,EXTERNAL X-LARGE FREEDOM CLEAR #5500/5530


name: CATHETER,EXTERNAL X-LARGE FREEDOM CLEAR SS #5510


name: CATHETER,INTERMITTENT LOFRIC CATH KIT 10FR ASTRATECH #911040


name: CATHETER,INTERMITTENT LOFRIC CATH KIT 12FR ASTRATECH #911240


name: CATHETER,INTERMITTENT LOFRIC CATH KIT 14FR ASTRATECH #911440